Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Moderna logoModerna MRNA

The company said it held its 2024 Annual Meeting of Stockholders on May 6, 2024 and that a quorum was present. Stockholders elected Robert Langer, Elizabeth Nabel and Elizabeth Tallett as Class III directors, each for a term of 3 years, until the 2027 Annual Meeting.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it held its 2024 Annual Meeting of Stockholders on May 6, 2024 and that a quorum was present. Stockholders elected Robert Langer, Elizabeth Nabel and Elizabeth Tallett as Class III directors, each for a term of 3 years, until the 2027 Annual Meeting.

  2. The company said stockholders approved an amendment to the charter giving holders of no less than 20% of outstanding shares the right to call a special meeting. Voting on Proposal 4 was 273,872,750 for, 586,572 against and 127,759 abstaining.

  3. The company said stockholders approved an amendment to the charter to reflect new Delaware law provisions allowing officer exculpation. Voting on Proposal 5 was 265,052,863 for, 9,259,011 against and 275,207 abstaining.

  4. The company said both charter amendments were filed with the Delaware Secretary of State and became effective on May 8, 2024, and the amended By-laws also took effect that day. Stockholders also approved the appointment of Ernst & Young LLP as auditor for the year ending December 31, 2024.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

2024 Annual Meeting Held and Class III Directors Elected

The company said it held its 2024 Annual Meeting of Stockholders on May 6, 2024 and that a quorum was present. Stockholders elected Robert Langer, Elizabeth Nabel and Elizabeth Tallett as Class III directors, each for a term of 3 years, until the 2027 Annual Meeting.

Source · Based on the filing body and exhibits

Special Meeting Amendment Approval Results

The company said stockholders approved an amendment to the charter giving holders of no less than 20% of outstanding shares the right to call a special meeting. Voting on Proposal 4 was 273,872,750 for, 586,572 against and 127,759 abstaining.

Source · Based on the filing body and exhibits

Officer Exculpation Amendment Approval Results

The company said stockholders approved an amendment to the charter to reflect new Delaware law provisions allowing officer exculpation. Voting on Proposal 5 was 265,052,863 for, 9,259,011 against and 275,207 abstaining.

Source · Based on the filing body and exhibits

Charter and By-law Amendments Effective, Auditor Appointment Approved

The company said both charter amendments were filed with the Delaware Secretary of State and became effective on May 8, 2024, and the amended By-laws also took effect that day. Stockholders also approved the appointment of Ernst & Young LLP as auditor for the year ending December 31, 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.